src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8050569412065003" crossorigin="anonymous">[/script]

Roche, Zealand Pharma strike $5.3 billion deal for obesity drug newsthirst.

Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Danish biotech Zealand Pharma’s obesity drug candidate, as the two firms seek to compete in the burgeoning weight loss drug market. The deal will see the two companies co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as…

Read More

New Zealand positive on U.S. trade ties despite tariff threat: Minister newsthirst.

Global tariff threats from U.S. President Donald Trump aside, New Zealand is optimistic about its trade relationship with the United States. Speaking to CNBC’s “Squawk Box Asia,” New Zealand Finance Minister Nicola Willis said that “New Zealand is distinguished in that we have a very balanced and complementary trade relationship with the United States,” adding…

Read More